For the Inventor, By the Inventor

Enter inventor name

Branchburg, NJ, United States of America

David I Stirling

USPTO Granted Patents = 43 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 24

Forward Citations = 2,656(Granted Patents)

Location History:

Fanwood, NJ (US) (1990 - 1994)
Branchburg., NJ (US) (2000)
Somerville, NJ (US) (2002 - 2010)
Branchburg, NJ (US) (1994 - 2012)
Warren, NJ (US) (2009 - 2014)
Basking Ridge, NJ (US) (2014 - 2018)

Company Filing History:

Celgene Corporation

Biotheryx, Inc.

Anthrogenesis Corporation

Celgene Corporation, Et Al.

5. 1 out of 832,912

Other

patents

Years Active: 1990-2018

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Biaryl Alkyl Amides

Stem Cell Differentiation

Pharmaceutical Compositions

Isoindoline Derivatives

Immunotherapeutic Aryl Amides

Stereoselective Synthesis

Chiral Amines

Phthalimides

Lactams

Cancer Treatment

Cachexia Treatment

Inflammatory Cytokines

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10106491 - Substituted biaryl alkyl amides (2018-10-23),

2. 9546131 - Substituted biaryl alkyl amides (2017-01-17),

3. 8889411 - Modulation of stem and progenitor cell differentiation, assays, and uses thereof (2014-11-18),

4. 8822527 - Substituted biaryl alkyl amides (2014-09-02),

5. 8288415 - Pharmaceutical compositions of 3-(4-amino-1-oxoisoindolin-2yl)-piperidine-2,6-dione (2012-10-16),

6. 8158653 - Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline (2012-04-17),

7. 7834033 - Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine (2010-11-16),

8. 7709502 - Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines (2010-05-04),

9. 7629360 - Methods for the treatment of cachexia and graft v. host disease (2009-12-08),

10. 7498171 - Modulation of stem and progenitor cell differentiation, assays, and uses thereof (2009-03-03),

11. 7459466 - Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNFα levels (2008-12-02),

12. 7329761 - Substituted imides (2008-02-12),

13. 7119106 - Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline (2006-10-10),

14. 7041680 - (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same (2006-05-09),

15. 7005438 - Pharmaceutically active isoindoline derivatives (2006-02-28),

Title: The Innovative Mind of David I Stirling

Introduction: David I Stirling, a brilliant inventor based in Branchburg, NJ (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: David I Stirling holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, David I Stirling has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries such as robotics, artificial intelligence, and renewable energy.

Collaborations: David I Stirling has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, David I Stirling stands as a testament to the power of human ingenuity and creativity in driving technological progress and shaping the future of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…